Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies

MD Kirkitadze, G Bitan… - Journal of neuroscience …, 2002 - Wiley Online Library
Alzheimer's disease (AD) is a progressive, neurodegenerative disorder characterized by
amyloid deposition in the cerebral neuropil and vasculature. These amyloid deposits …

Amyloid precursor protein, presenilins, and α-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease

YH Suh, F Checler - Pharmacological reviews, 2002 - ASPET
Alzheimer's disease (AD) is the most common cause of dementia that arises on a
neuropathological background of amyloid plaques containing β-amyloid (Aβ) derived from …

α-Synuclein is phosphorylated in synucleinopathy lesions

H Fujiwara, M Hasegawa, N Dohmae… - Nature cell …, 2002 - nature.com
The deposition of the abundant presynaptic brain protein α-synuclein as fibrillary aggregates
in neurons or glial cells is a hallmark lesion in a subset of neurodegenerative disorders …

[HTML][HTML] Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein

BI Giasson, JE Duda, SM Quinn, B Zhang… - Neuron, 2002 - cell.com
Abstract α-Synucleinopathies are neurodegenerative disorders that range pathologically
from the demise of select groups of nuclei to pervasive degeneration throughout the …

Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease

PK Auluck, HYE Chan, JQ Trojanowski, VMY Lee… - Science, 2002 - science.org
Parkinson's disease is a movement disorder characterized by degeneration of dopaminergic
neurons in the substantia nigra pars compacta. Dopaminergic neuronal loss also occurs in …

Where does parkinson disease pathology begin in the brain?

K Del Tredici, U Rüb, RAI De Vos… - … of Neuropathology & …, 2002 - academic.oup.com
The substantia nigra is not the induction site in the brain of the neurodegenerative process
underlying Parkinson disease (PD). Instead, the results of this semi-quantitative study of 30 …

Parkinson-like neurodegeneration induced by targeted overexpression of α-synuclein in the nigrostriatal system

D Kirik, C Rosenblad, C Burger… - Journal of …, 2002 - Soc Neuroscience
Recombinant adeno-associated viral vectors display efficient tropism for transduction of the
dopamine neurons of the substantia nigra. Taking advantage of this unique property of …

Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→ Thr mutation causes neurodegenerative disease with α-synuclein aggregation in …

MK Lee, W Stirling, Y Xu, X Xu, D Qui… - Proceedings of the …, 2002 - National Acad Sciences
Mutations in α-synuclein (α-Syn) cause Parkinson's disease (PD) in a small number of
pedigrees with familial PD. Moreover, α-Syn accumulates as a major component of Lewy …

Dependence of α-synuclein aggregate morphology on solution conditions

W Hoyer, T Antony, D Cherny, G Heim, TM Jovin… - Journal of molecular …, 2002 - Elsevier
α-Synuclein is the major component of Lewy bodies and Lewy neurites, which are granular
and filamentous protein inclusions that are the defining pathological features of several …

[HTML][HTML] The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice: paraquat and α-synuclein

AB Manning-Bog, AL McCormack, J Li… - Journal of Biological …, 2002 - ASBMB
α-Synuclein-containing aggregates represent a feature of a variety of neurodegenerative
disorders, including Parkinson's disease (PD). However, mechanisms that promote …